Stay updated on Nivolumab in Salivary Gland Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Salivary Gland Carcinoma Clinical Trial page
- Check3 days agoChange DetectedA new revision tag v3.6.2 appears on the page, replacing the previous v3.6.0. This indicates a version update of the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecruitment status now indicates no current enrollment, and new help/navigation sections aid user understanding. The Intervention/Treatment heading was adjusted and the page revision was updated to v3.6.0 to reflect these changes.SummaryDifference0.4%

- Check24 days agoChange DetectedRevision number updated from v3.5.4 to v3.5.5, indicating a minor page update in the site's versioning. No study content or data appear to be changed.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page footer revision tag was updated from Revision: v3.5.3 to Revision: v3.5.4, indicating a minor software version update for the page.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s displayed revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Salivary Gland Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.